People · Operator
Named in public records as an officer, director or promoter · active 2009–2024 · Biotechnology, Other Health Care, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Alphyn Biologics, Inc. | — | Biotechnology | Series A | $9.3M | $30.8M | 2024 |
| Rhinocyte Inc | — | Other Health Care | Seed | $3.8M | $6.2M | 2014 |
| Charles H Mack & Associates Inc | — | Other Technology | Seed | $3.1M | $12.8M | 2009 |
Tony Shipley at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Tony Shipley on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Chris Eldridge | 1 | 7 |
| Jay Katarincic | 1 | 6 |
| Tom Jones | 1 | 4 |
| Stephen Baker | 1 | 3 |
| Jason Tomlinson | 1 | 3 |
| Steve Gailar | 1 | 2 |
| Roger Griggs | 1 | 2 |
| George L Emont | 1 | 1 |
| Steven Pentelnik | 1 | 1 |
| Jeffrey Kossak | 1 | 1 |
| Gary Pekoe | 1 | 1 |
| Adel Mikhail | 1 | 1 |
| Neal Koller | 1 | 1 |
| Teresa Leezer | 1 | 1 |
| Jason J Tomlinson | 1 | 1 |
| Steven J Gailar | 1 | 1 |
| Dr. Fred J Roisen | 1 | 1 |
| Fred Roisen | 1 | 1 |
| Damian Hazeley | 1 | 1 |
| Gregory Silence | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.